nad has been researched along with Arteriosclerosis Obliterans in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
AGUSTINARZENO, J; DEFERNANDEZBLANCO, JF; FERNANDEZBLANCO, E | 1 |
Brücke, P; Kaufmann, F; Piza, F | 1 |
2 other study(ies) available for nad and Arteriosclerosis Obliterans
Article | Year |
---|---|
[7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1, 3-DIMETHYL-XANTHINE NICOTINATE IN CHRONIC OBLITERATING ANGIOPATHIES].
Topics: Arteriosclerosis; Arteriosclerosis Obliterans; Cholesterol; Coronary Disease; Humans; Intracranial Arteriosclerosis; Lipid Metabolism; NAD; Niacin; Nicotinic Acids; Pharmacology; Theophylline; Toxicology; Vascular Diseases; Vasodilator Agents; Vasomotor System; Xanthine | 1963 |
[On the morphologic and histochemical behavior of the blood vessel wall in arterial obstruction].
Topics: Adenosine Triphosphatases; Alkaline Phosphatase; Animals; Aorta; Arteriosclerosis Obliterans; Dihydrolipoamide Dehydrogenase; NAD; Rats | 1966 |